According to the latest report by IMARC Group,The global artificial heart-lung machine market reached a value of US$ 319.3 Million in 2020.An artificial heart-lung machine (HLM), also known as a cardiopulmonary bypass pump, refers to an apparatus that performs the function of both the heart and lungs during open-heart surgery or a transplant. It ensures that the blood receives oxygen and removes carbon dioxide before the blood is pumped back into the body.

1. Copyright © IMARC Service Pvt Ltd. All Rights Reserved
Global Artificial Heart-Lung
Machine Market
Research Report and
Forecast 2021-2026
Author: Elena Anderson,
Marketing Manager |
IMARC Group
© 2019 IMARC All Rights Reserved

2. Report Description
About IMARC Group
The International Market Analysis Research and Consulting Group is a leading adviser on
management strategy and market research worldwide. We partner with clients in all sectors
and regions to identify their highest-value opportunities, address their most critical
challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological
developments for business leaders in pharmaceutical, industrial, and high technology
organizations. Market forecasts and industry analysis for biotechnology, advanced materials,
chemicals, food and beverage, travel and tourism, nanotechnology and novel processing
methods are at the top of the company’s expertise.
IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and
markets with close cooperation at all levels of the client organization. This ensures that our
clients achieve unmatchable competitive advantage, build more proficient organizations, and
secure lasting results.

3. Report Description
Report Description and Highlights
Global Artificial Heart-Lung Machine Market Outlook 2026:
IMARC Group’s latest report, titled “Artificial Heart-Lung Machine Market: Global Industry Trends,
Share, Size, Growth, Opportunity and Forecast 2021-2026”, finds that The global artificial heart-lung
machine market reached a value of US$ 319.3 Million in 2020.
An artificial heart-lung machine (HLM), also known as a cardiopulmonary bypass pump, refers to an
apparatus that performs the function of both the heart and lungs during open-heart surgery or a
transplant. It ensures that the blood receives oxygen and removes carbon dioxide before the blood is
pumped back into the body.
It keeps the patient alive during heart transplants and has formed the basis of the medical support
given to premature babies and those with respiratory or cardiac problems for extended periods. Some
of the main components of an HLM include pump, heat exchanger, oxygenator, filter, temperature
regulator and connecting tube.
Request for a free sample: https://www.imarcgroup.com/artificial-heart-lung-machine-
market/requestsample

4. Report Description
Report Description and Highlights
Global Artificial Heart-Lung Machine Market Trends:
According to the 2016 estimates of the World Health Organization (WHO), approximately 17.9 million
people die from cardiovascular diseases (CVDs) per year, representing 31% of all the global deaths. The
high prevalence of CVDs, along with improved access to healthcare facilities, has led to a consequent
rise in the number of open-heart surgeries or coronary interventions performed worldwide, which in
turn has increased the demand for HLMs.
Apart from this, the leading firms are engaged in continuous innovation with global research and
development (R&D) centers for introducing better technologies to improve patient heart conditions.
For instance, LivaNova.
A global medical technology company, has designed machines ranging from small, compact HLMs
equipped with three roller pumps to full-featured systems with seven roller pumps and the full range
of control and monitoring functions.

5. Market Summary:
Breakup by Type:
• Single Roller Pump
• Double Roller Pump
Breakup by Application:
• Cardiac Surgeries
• Lung Surgeries
• Acute Respiratory Failure Treatment
Breakup by End User:
• Hospitals and Clinics
• Ambulatory Surgical Centers
Report Description
Report Description and Highlights

6. Breakup by Region:
• North America
• Asia Pacific
• Europe
• Middle East and Africa
• Latin America
Looking forward, IMARC Group expects the market to grow at a CAGR of 6.2% during 2021-2026.
Report Description
Report Description and Highlights

7. Competitive Landscape With Key players:
• Medtronic Inc
• Sorin Group
• MAQUET GmbH & Co. KG
• Terumo Corporation
• C.R. Bard Inc
• Tianjin Medical
• Edwards Lifesciences
• Jarvik Heart
• Braile Biomedica
• SynCardia
View Report TOC, Figures and Tables: https://www.imarcgroup.com/artificial-heart-lung-machine-
market
Report Description
Report Description and Highlights

8. A partial List of our Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
Partial List of Clients

9. A partial List of our Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
Partial List of Clients

10. Report Description
Report Description and Highlights
© 2019 IMARC All Rights Reserved
This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of
International Market Analysis Research and Consulting (IMARC). No part of this publication may be
reproduced, repackaged, redistributed or resold in whole or in any part. The publication may also not be
used in any form or by and means graphic electronic or mechanical, including photocopying, recording,
taping or by information storage or retrieval, or by any other form, without the express consent of
International Market Analysis Research and Consulting (IMARC).
Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion have been
based on information and sources believed to be accurate and reliable at the time of publishing.
International Market Analysis Research and Consulting makes no representation of warranty of any kind as to
the accuracy or completeness of any Information provided. IMARC accepts no liability whatsoever for any
loss or damage resulting from opinion, errors or inaccuracies if any found this publication.
IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International Market
Analysis Research and Consulting. All other trademarks used in this publication are registered trademarks of
their respective companies.

11. FOR MORE DETAILS
Visit us at :
Stay With Us:
TELEPHONE: +1-631-791-1145
E-MAIL: sales@imarcgroup.com
https://www.imarcgroup.com
Contact Us